Developmental Research Program
- Institution
- UNIV OF NORTH CAROLINA CHAPEL HILL, NC
- Principal investigator
- H. Shelton Earp
- Funding
- $76K
- Duration
- 1997–2029
Moonbase score
Still being scored
Abstract
Developmental Research Program - Abstract The UNC Breast Cancer SPORE Developmental Research Program (DRP) has promoted novel breast cancer research across the population, translational, and clinical arenas since 1992. This highly successful Program includes mechanisms for stimulating grant applications, rigorously evaluating proposals, selecting projects with advocate input, and monitoring progress. Application mechanisms include both regular competitive awards as well as rapidly emerging opportunities. Evaluation and selection processes include a well-established, independent scientific peer review that includes patient advocates. The SPORE Multi-PIs Perou and Carey, with input from the Executive Committee, make final decisions regarding selection and budget. We expanded formal solicitation to other UNC system universities to continue to grow the faculty with the most innovative ideas to improve breast cancer prevention, early detection, therapy and survivorship care. The program has increased in the past decade with increased institutional commitment to expanded faculty recruitment. The process will feature a robust twice-yearly solicitation for competitive DRP awards across UNC and our sister UNC System universities. UNC Lineberger’s commitment to the Breast SPORE goes beyond this, with the Multi-PIs and Cancer Center investing directly in major programs (e.g., CBCS Phase 4), infrastructures (tripling of the size of the cellular therapy GMP facility) and technology (a NovaSeq X and CosMx purchase). The Multi-PIs co-conceptualize the emerging investments with the needs of both innovative science and the CEP recruits in mind.
LOADING MOONBASE SCORE
Questions for UNIV OF NORTH CAROLINA CHAPEL HILL
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Univ of North Carolina Chapel HillNot yet scored
Divergent Roles of MerTK,Tyro3, and Axl in Pancreatic Cancer and Metastasis
H. Shelton Earp · $537K · 2022–2027
- NIH · Univ of North Carolina Chapel Hill65
Cortical circuits for the integration of parallel short-latency auditory pathways
Hiroyuki Kato · $469K · 2022–2027
- NIH · Univ of North Carolina Chapel Hill47
Study to establish safety, tolerability and feasibility of LM11A-31 as a neuroprotective agent in aging people living with HIV and neurocognitive impairment on antiretroviral therapy
Rick B Meeker · $638K · 2023–2029